Literature DB >> 26657100

Targeted Therapies Improve Outlook for Chronic Lymphocytic Leukemia.

Vicki Brower.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26657100     DOI： 10.1093/jnci/djv396

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  1 in total

1.  A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemia.

Authors:  Neil E Kay; Paolo Strati; Betsy R LaPlant; Jose F Leis; Daniel Nikcevich; Timothy G Call; Adam M Pettinger; Connie E Lesnick; Curtis A Hanson; Tait D Shanafelt
Journal:  Oncotarget       Date:  2016-11-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.